As for AD, both overexpression and infusion of human APOA-I have been shown to reduce neuroinflammation, inhibit cerebral amyloid angiopathy (CAA), and improve cognitive performance in transgenic mouse models [84,156]. This evidence concerns the gene APOA1 and Alzheimer disease.